As more combinations of image guidance and therapeutic modalities mature clinically, IGT growth opportunities diversify and start to materialize
Santa Clara, Calif. – September 19, 2017 – The medical imaging industry has evidenced significant effort and investment toward the development of next-generation therapeutic and diagnostic imaging techniques. While recent advances in imaging technology and progresses in therapeutics offer the potential for precise and image-guided therapies (IGT) that will transform existing approaches like surgical planning, interventional technique and monitoring therapeutic response, a single-integrated IGT platform, will pave the way for multi-modality integration and image fusion to target specific therapies and cancer treatments.
Frost & Sullivan’s research, Developments in Image-guided Therapy, sheds light on the IGT technology landscape, critical business and technology considerations that are aiding and hampering market adoption, areas that present opportunities for growth, and current research activities.
“A universal IGT platform promises to drive multi-modality integration in the hybrid digital operating rooms. This will result in unprecedented integration capabilities as well as enable new non-invasive procedures, improve post-operative outcomes, and increase speed of surgical processes,” stated Transformational Health Industry Analyst Dinesh Kumar
As the IGT market matures, the demand for single vendors offering enterprise-wide imaging informatics solutions will stimulate partnerships, collaborations, and merger and acquisition activities. For example, Philips Healthcare’s strategic partnership with Elekta has led to the development of the world’s first high-field integrated magnetic resonance imaging-guided radiation therapy (MR-LINAC) technology.
Other companies providing innovative IGT products and solutions include:
- Elekta’s Venezia hybrid image-guided brachytherapy applicator received 510(k) clearance from the U.S. Food and Drug Administration (FDA) in February 2017 for the treatment of advanced-stage cervical cancers.
- Accuray’s Cyberknife provides an effective treatment option with minimal side effects for various cancer treatments, including long-term disease control for prostate cancer patients.
- GE Healthcare’s image-guided system for interventional radiology and oncology supports complex endovascular procedures and minimally invasive surgeries.
- Brainlab’s Curve technology empowers surgeons with a state-of-the-art IGS solution that acts as a command-and-control center for accomplishing successful image-guided surgery. This solution covers all sub-specialties from neurosurgery to spinal surgery.
- Varian Medical System’s TrueBeam platform is an integrated system for image-guided radiotherapy and radiosurgery.
“The lack of a universal platform that can synchronize disparate systems into a single integrated enterprise solution to treat specific conditions makes the healthcare environment extremely fragmented,” noted Kumar. “Limited interoperability standards and a large installed base of legacy imaging equipment, and IT systems are factors further restraining IGT market adoption and growth.”
To access more information on this analysis, please click here.
Developments in Image-guided Therapy is part of Frost & Sullivan’s Advanced Medical Technologies Growth Partnership Service program.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Contact us: Start the discussion
Developments in Image-guided Therapy
9AB9_23
Contact:
Mariana Fernandez
Corporate Communications – North America
P: +1 (210) 348 1012
